TherapeuticsMD, Inc.
NASDAQ: TXMD0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Select
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Marlan D. Walker
- Employees
- 1
- Headquarters
- Boca Raton, United States
- IPO year
- 2007
- Market cap
- $23.3M
- Website
- https://www.therapeuticsmd.com
Loading TXMD…
Loading profile data…Frequently asked questions about TXMD
What does TherapeuticsMD, Inc. (TXMD) do?
TherapeuticsMD, Inc. is a U.S.-based pharmaceutical company dedicated to women's health. Its marketed portfolio includes IMVEXXY, prescribed for moderate to severe dyspareunia; BIJUVA, a bio-identical hormone replacement therapy combining 17ß-estradiol and progesterone, used to alleviate moderate to severe vasomotor symptoms; and ANNOVERA, an in...
Where does TXMD trade?
TherapeuticsMD, Inc. (TXMD) trades on the NASDAQ Global Select.
What sector is TXMD in?
TherapeuticsMD, Inc. (TXMD) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of TherapeuticsMD, Inc.?
Marlan D. Walker is the chief executive officer of TherapeuticsMD, Inc. (TXMD).
Where is TherapeuticsMD, Inc. headquartered?
TherapeuticsMD, Inc. is headquartered in United States.
Does TXMD pay a dividend?
TherapeuticsMD, Inc. (TXMD) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did TXMD go public?
TherapeuticsMD, Inc. (TXMD) completed its initial public offering in 2007.